Masleidy Fornos Artiles
Nurse Practitioner · Naples, FLNPI 1851067730
Payments from drug & device makers
Across 235 payments — averaging $25.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$599
- AstraZeneca$445
- Takeda Pharmaceuticals U.S.A., Inc.$394
- Novo Nordisk$386
- Mannkind Corporation$352
- Amgen$294
- plus $4K from 41 others
What the payments were for
- Food & beverage$6,036100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,048 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 149 | $240,781 |
| OzempicSemaglutide | 95 | $160,576 |
| TrulicityDulaglutide | 78 | $115,367 |
| JardianceEmpagliflozin | 56 | $74,602 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $40,254 |
| TradjentaLinagliptin | 27 | $30,780 |
| FarxigaDapagliflozin Propanediol | 17 | $25,653 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 18 | $24,655 |
| Lyumjev Kwikpen U-100Insulin Lispro-Aabc | 17 | $18,777 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $18,706 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $17,311 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 51 | $9,023 |
| Humalog Kwikpen U-100Insulin Lispro | 26 | $7,212 |
| SynthroidLevothyroxine Sodium | 53 | $5,245 |
| Novolog FlexpenInsulin Aspart | 13 | $4,414 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $599 | $359,809239 claims |
| Novo NordiskOzempic | $386 | $160,57695 claims |
| Boehringer IngelheimJardiance, Tradjenta | $186 | $105,38283 claims |
| AstraZenecaFarxiga | $445 | $25,65317 claims |
| AbbVieSynthroid | $108 | $5,24553 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $166 | $1,417152 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Naples
- Stephanie SimmermanNaples$283K
- Doreen CassarinoNaples$41K
- Tara McGaheyNaples$21K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.